Category: Research

Research we’re funding in partnership with The Oli Hilsdon Foundation at University College London is using advanced brain mapping to reveal how glioblastoma spreads and resists treatment, providing insight for potential new treatments.

This year has been an exciting year for our research. Read more as we share some of 2024’s best bits.

Caring for someone with a lower-grade glioma has a profound impact on the lives of carers. The Ways Ahead Project aims to better understand this to inform the best ways to support those affected.

Involvement volunteer Baljit Ahluwalia lost her mother, Harbans Kaur Walia, to glioblastoma in 2020.

Bryony Powell knew very little about brain tumours before her fiancé, Catherine Roberts, was diagnosed with a glioblastoma in April 2018.

The blood-brain barrier poses challenges for treating brain tumours. We hope that by funding pioneering research we can help improve brain tumour treatment.

As a charity, we’ve been to lots of scientific conferences this year, with one more to come this year. We attend these conferences to ensure that we are at the forefront of important research topics in the brain tumour field.

We’re delighted to announce that The Jake McCarthy Foundation has donated £30,000 towards Dr Tyler Miller’s research into combating gliomas with immunotherapy

We are pleased to announce the two researchers who have been awarded our latest Expanding Theories grant!

The biennial CRUK Brain Tumour Conference returned to London for 2024.

Researchers in Newcastle have found a key genetic variation in medulloblastomas that may pave the way for more effective targeted treatments.

Mum of three Emma, 41, from Lowestoft, made several medical appointments before she was diagnosed with multiple meningiomas in 2022.

We’re proud to announce the latest recipients of our Future Leaders grants that’ve been awarded for their innovative new research projects.

Our Junior Fellow Dr Spencer Watson and his team at The Ludwig Institute for Cancer Research at the University of Lausanne in Switzerland are researching new ways to treat glioblastoma.

This month we sponsored an event in Manchester which brought together brain tumour experts to talk about new technologies that could improve brain tumour care.

The National Institute for Health and Care Research (NIHR) has announced two new calls for research into brain tumours.

With our funding, researchers in Canada have found key features in different meningiomas that can help predict tumour response to the most common treatments.

Ribociclib – a drug already used to treat breast cancer – may help slow the growth of diffuse hemispheric glioma.

An international phase 3 clinical trial has shown that vorasidenib could be a new targeted treatment for those diagnosed with a low-grade glioma.

As Artificial Intelligence (AI) becomes more common in our day-to-day life, what does this mean for the future of research into brain tumours?

We are pleased to announce that we have awarded £3 million to two new, exciting research projects!

Innovative imaging technology and machine learning developed by our Future Leader, Dr Spencer Watson, helps us understand how glioblastomas respond to treatment.

One of our first Junior Fellowship grant holders, Dr Tyler Miller, has opened his own research lab focused on developing immunotherapies to treat brain tumours.

The guidelines recently published by NICE mean that NHS England will be using dabrafenib and trametinib – the first ever targeted treatment for childhood brain tumours – to treat children whose tumours have a BRAF V600E mutation.